Found: 59
Select item for more details and to access through your institution.
Increased soluble Fas-ligand in sera of bone marrow transplant recipients with acute graft-versus-host disease.
- Published in:
- Bone Marrow Transplantation, 1998, v. 22, n. 8, p. 751, doi. 10.1038/sj.bmt.1701427
- By:
- Publication type:
- Article
Whole saliva albumin as an indicator of stomatitis in cancer therapy patients.
- Published in:
- 1981
- By:
- Publication type:
- journal article
Intensive chemotherapy for elderly patients with acute myelogeneous leukemia: a propensity score analysis by the Japan Hematology and Oncology Clinical Study Group (J-HOCS)
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Prostaglandin activity and sulcular flow in carrageenan-injected gingiva of the dog.
- Published in:
- Journal of Periodontal Research, 1984, v. 19, n. 1, p. 14, doi. 10.1111/j.1600-0765.1984.tb01191.x
- By:
- Publication type:
- Article
Sialochemistry of Whole, Parotid, and Labial Minor Gland Saliva in Patients with Oral Lichen Planus.
- Published in:
- Journal of Dental Research, 1987, v. 66, n. 11, p. 1619, doi. 10.1177/00220345870660110201
- By:
- Publication type:
- Article
Iatrogenic Causes of Salivary Gland Dysfunction.
- Published in:
- Journal of Dental Research, 1987, v. 66, p. 680, doi. 10.1177/00220345870660S213
- By:
- Publication type:
- Article
Use of Human Minor Salivary Glands in Basic and Applied Secretion Research.
- Published in:
- Journal of Dental Research, 1987, v. 66, p. 654, doi. 10.1177/00220345870660S208
- By:
- Publication type:
- Article
Intracellular Elemental Concentrations in Resting and Secreting Rat Parotid Glands.
- Published in:
- Journal of Dental Research, 1987, v. 66, n. 2, p. 537, doi. 10.1177/00220345870660022501
- By:
- Publication type:
- Article
Age-related Salivary Flow Rate Changes in Controls and Patients with Oral Lichen Planus.
- Published in:
- Journal of Dental Research, 1985, v. 64, n. 9, p. 1149, doi. 10.1177/00220345850640091101
- By:
- Publication type:
- Article
Age-dependent Decreases in Human Submandibular Gland Flow Rates as Measured Under Resting and Post-stimulation Conditions.
- Published in:
- Journal of Dental Research, 1985, v. 64, n. 5, p. 822, doi. 10.1177/00220345850640050801
- By:
- Publication type:
- Article
Permeability of Oral Mucosa to Organic Compounds.
- Published in:
- Journal of Dental Research, 1980, v. 59, n. 10, p. 1604, doi. 10.1177/00220345800590100801
- By:
- Publication type:
- Article
Quantitative elemental imaging in the analytical electron microscope with biological applications.
- Published in:
- Scanning, 1989, v. 11, n. 1, p. 12, doi. 10.1002/sca.4950110104
- By:
- Publication type:
- Article
I.v. BU/fludarabine plus melphalan or TBI in unrelated cord blood transplantation for high-risk hematological diseases.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 607, doi. 10.1038/bmt.2014.316
- By:
- Publication type:
- Article
High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2005, v. 36, n. 9, p. 813, doi. 10.1038/sj.bmt.1705134
- By:
- Publication type:
- Article
Cardiac complications after haploidentical HLA-mismatched hematopoietic stem cell transplantation using in vivo alemtuzumab.
- Published in:
- Bone Marrow Transplantation, 2005, v. 36, n. 9, p. 821, doi. 10.1038/sj.bmt.1705145
- By:
- Publication type:
- Article
Predictors for severe cardiac complications after hematopoietic stem cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2004, v. 33, n. 10, p. 1043, doi. 10.1038/sj.bmt.1704487
- By:
- Publication type:
- Article
Increased incidence of acute graft-versus-host disease with the continuous infusion of cyclosporine A compared to twice-daily infusion.
- Published in:
- Bone Marrow Transplantation, 2004, v. 33, n. 5, p. 549, doi. 10.1038/sj.bmt.1704374
- By:
- Publication type:
- Article
Male predominance among Japanese adult patients with late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2003, v. 32, n. 12, p. 1175, doi. 10.1038/sj.bmt.1704274
- By:
- Publication type:
- Article
Transplantation for accidental acute high-dose total body neutron- and Υ-radiation exposure.
- Published in:
- 2002
- By:
- Publication type:
- Case Study
Comparison of outcomes between autologous and allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphomas with central review of pathology.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 6, p. 1394, doi. 10.1038/leu.2012.321
- By:
- Publication type:
- Article
Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate.
- Published in:
- Leukemia (08876924), 2004, v. 18, n. 5, p. 1013, doi. 10.1038/sj.leu.2403343
- By:
- Publication type:
- Article
Identification of a novel fusion gene, TTL, fused to ETV6 in acute lymphoblastic leukemia with t(12;13)(p13;q14), and its implication in leukemogenesis.
- Published in:
- Leukemia (08876924), 2003, v. 17, n. 6, p. 1112, doi. 10.1038/sj.leu.2402919
- By:
- Publication type:
- Article
Therapy-induced dysfunction of salivary glands: implications for oral health.
- Published in:
- 1985
- By:
- Publication type:
- journal article
PHASE 3 TRIAL OF SUBCUTANEOUS EPCORITAMAB + R‐CHOP VERSUS R‐CHOP IN PATIENTS (PTS) WITH NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): EPCORE DLBCL‐2.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 849, doi. 10.1002/hon.3166_OT28
- By:
- Publication type:
- Article
TRANSCEND FL: PHASE 2 STUDY RESULTS OF LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL).
- Published in:
- Hematological Oncology, 2023, v. 41, p. 877, doi. 10.1002/hon.3196_LBA4
- By:
- Publication type:
- Article
Duvelisib in patients with relapsed/refractory peripheral T‐cell lymphoma from the phase 2 PRIMO Trial Expansion Phase: outcomes by baseline histology.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 499, doi. 10.1002/hon.3164_367
- By:
- Publication type:
- Article
IMMUNE CONTEXTURE ANALYSIS IN POLARIX SUGGESTS RESPONSE TO POLA‐R‐CHP TREATMENT REDUCES TUMOR MICROENVIRONMENT DEPENDENCY.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 223, doi. 10.1002/hon.3163_146
- By:
- Publication type:
- Article
PIRTOBRUTINIB IN COVALENT BTK‐INHIBITOR PRE‐TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS, SUBGROUP ANALYSIS FROM BRUIN WITH >3 YEARS FOLLOW‐UP FROM START OF ENROLLMENT.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 153, doi. 10.1002/hon.3163_102
- By:
- Publication type:
- Article
ESCALADE: A PHASE 3 STUDY OF ACALABRUTINIB IN COMBINATION WITH R‐CHOP FOR PATIENTS ≤65Y WITH UNTREATED NON‐GERMINAL CENTER B‐CELL–LIKE DIFFUSE LARGE B‐CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.164_2880
- By:
- Publication type:
- Article
FIRST‐IN‐HUMAN STUDY OF THE EZH1 AND EZH2 DUAL INHIBITOR VALEMETOSTAT TOSYLATE (DS‐3201B) IN PATIENTS WITH RELAPSED OR REFRACTORY NON‐HODGKIN LYMPHOMAS.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.14_2879
- By:
- Publication type:
- Article
A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TUCIDINOSTAT (HBI‐8000) IN JAPANESE PATIENTS WITH RELAPSED OR REFRACTORY ADULT T‐CELL LEUKEMIA‐LYMPHOMA (ATL)
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.122_2880
- By:
- Publication type:
- Article
A PHASE 2B OPEN‐LABEL SINGLE ARM STUDY TO EVALUATE THE EFFICACY AND SAFETY OF HBI‐8000 (TUCIDINOSTAT) IN PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T‐CELL LYMPHOMA (PTCL)
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.121_2880
- By:
- Publication type:
- Article
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA PATIENTS RELAPSING AFTER HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION: DATA FROM THE JAPAN SOCIETY FOR HEMATOPOIETIC CELL TRANSPLANTATION (JSHCT) REGISTRY
- Published in:
- Hematological Oncology, 2019, v. 37, p. 266, doi. 10.1002/hon.75_2630
- By:
- Publication type:
- Article
AUGMENT PHASE III STUDY: LENALIDOMIDE/RITUXIMAB (R<sup>2</sup>) IMPROVED EFFICACY OVER RITUXIMAB/PLACEBO IN RELAPSED/REFRACTORY FOLLICULAR PATIENTS IRRESPECTIVE OF POD24 STATUS.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 114, doi. 10.1002/hon.75_2629
- By:
- Publication type:
- Article
THE ROLE OF SURVEILLANCE COMPUTED TOMOGRAPHY IN PATIENTS WITH FOLLICULAR LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 395, doi. 10.1002/hon.65_2631
- By:
- Publication type:
- Article
CLINICAL SIGNIFICANCE OF UPTAKE VALUE ON F18‐FDG PET/CT AND HISTOLOGICAL GRADE IN 164 PATIENTS WITH FOLLICULAR LYMPHOMA INCLUDING TRANSFORMATION – A SINGLE CENTER RETROSPECTIVE STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 393, doi. 10.1002/hon.63_2631
- By:
- Publication type:
- Article
ROBUST: First report of phase III randomized study of lenalidomide/R‐CHOP (R<sup>2</sup>‐CHOP) vs placebo/R‐CHOP in previously untreated ABC‐type diffuse large B‐cell lymphoma.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 36, doi. 10.1002/hon.5_2629
- By:
- Publication type:
- Article
HEALTH‐RELATED QUALITY OF LIFE (HRQoL) IN RELAPSED/REFRACTORY (R/R) INDOLENT NHL IN THE PHASE 3 AUGMENT TRIAL OF RITUXIMAB (R) PLUS LENALIDOMIDE (R<sup>2</sup>) VERSUS R PLUS PLACEBO.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 232, doi. 10.1002/hon.45_2630
- By:
- Publication type:
- Article
AUGMENT: RELAPSED/REFRACTORY INDOLENT NHL PATIENTS WERE MORE SENSITIVE TO NEXT TREATMENT FOLLOWING LENALIDOMIDE/RITUXIMAB (R<sup>2</sup>) THAN RITUXIMAB/PLACEBO.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 227, doi. 10.1002/hon.42_2630
- By:
- Publication type:
- Article
POST HOC ANALYSES OF PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA WHO RECEIVED LENALIDOMIDE PLUS RITUXIMAB (R<sup>2</sup>) VS RITUXIMAB/PLACEBO (AUGMENT).
- Published in:
- Hematological Oncology, 2019, v. 37, p. 226, doi. 10.1002/hon.41_2630
- By:
- Publication type:
- Article
INTRAVENOUS IMMUNOGLOBULIN THERAPY USE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL IN THE JULIET TRIAL.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 505, doi. 10.1002/hon.189_2631
- By:
- Publication type:
- Article
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH AGGRESSIVE NATURAL KILLER CELL LEUKEMIA: A NATIONWIDE MULTICENTER ANALYSIS IN JAPAN.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 479, doi. 10.1002/hon.158_2631
- By:
- Publication type:
- Article
CORRELATIVE ANALYSES OF CYTOKINE RELEASE SYNDROME AND NEUROLOGICAL EVENTS IN TISAGENLECLEUCEL‐TREATED RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 308, doi. 10.1002/hon.118_2630
- By:
- Publication type:
- Article
CLINICAL SIGNIFICANCE OF UPTAKE VALUE ON F18‐FDG PET/CT AND HISTOLOGICAL GRADE IN 164 PATIENTS WITH FOLLICULAR LYMPHOMA INCLUDING TRANSFORMATION – A SINGLE CENTER RETROSPECTIVE STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 393, doi. 10.1002/hon.63_2631
- By:
- Publication type:
- Article
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA PATIENTS RELAPSING AFTER HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION: DATA FROM THE JAPAN SOCIETY FOR HEMATOPOIETIC CELL TRANSPLANTATION (JSHCT) REGISTRY
- Published in:
- Hematological Oncology, 2019, v. 37, p. 266, doi. 10.1002/hon.75_2630
- By:
- Publication type:
- Article
AUGMENT PHASE III STUDY: LENALIDOMIDE/RITUXIMAB (R<sup>2</sup>) IMPROVED EFFICACY OVER RITUXIMAB/PLACEBO IN RELAPSED/REFRACTORY FOLLICULAR PATIENTS IRRESPECTIVE OF POD24 STATUS.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 114, doi. 10.1002/hon.75_2629
- By:
- Publication type:
- Article
THE ROLE OF SURVEILLANCE COMPUTED TOMOGRAPHY IN PATIENTS WITH FOLLICULAR LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 395, doi. 10.1002/hon.65_2631
- By:
- Publication type:
- Article
ROBUST: First report of phase III randomized study of lenalidomide/R‐CHOP (R<sup>2</sup>‐CHOP) vs placebo/R‐CHOP in previously untreated ABC‐type diffuse large B‐cell lymphoma.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 36, doi. 10.1002/hon.5_2629
- By:
- Publication type:
- Article
HEALTH‐RELATED QUALITY OF LIFE (HRQoL) IN RELAPSED/REFRACTORY (R/R) INDOLENT NHL IN THE PHASE 3 AUGMENT TRIAL OF RITUXIMAB (R) PLUS LENALIDOMIDE (R<sup>2</sup>) VERSUS R PLUS PLACEBO.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 232, doi. 10.1002/hon.45_2630
- By:
- Publication type:
- Article
AUGMENT: RELAPSED/REFRACTORY INDOLENT NHL PATIENTS WERE MORE SENSITIVE TO NEXT TREATMENT FOLLOWING LENALIDOMIDE/RITUXIMAB (R<sup>2</sup>) THAN RITUXIMAB/PLACEBO.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 227, doi. 10.1002/hon.42_2630
- By:
- Publication type:
- Article